The alternative text for this image may have been generated using AI. Because these chromatin marks seem to be maintained differentially on essentially identical alleles over many cell generations, it ...

c.156_157insAlu is a founder mutation of Portuguese origin and is the most frequent BRCA2 rearrangement described to date.

The FDA Friday approved pemigatinib (Pemazyre), a selective fibroblast growth factor (FGFR) inhibitor, to treat adults who have relapsed or refractory (R/R) myeloid/lymphoid neoplasms (MLNs) with ...

Duplications and deletions in the human genome can cause disease or predispose persons to disease. Advances in technologies to detect these changes allow for the routine identification of ...

The Jingjing Wu group at the National Key Laboratory of Synergistic Materials Creation/Frontier Science Center for Transformative Molecules (FSCTM) at Shanghai Jiao Tong University, in collaboration ...

Phase II trial of bortezomib in KRAS G12D mutant lung cancers. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.

Scientists harness a new-to-nature reaction in E. coli to turn discarded plastics into life-saving medicines, charting a sustainable path for chemical manufacturing. a, A comparison of strategies for ...